Neonatal Abstinence Syndrome Booklet
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Caring for the Infant with Neonatal Abstinence Syndrome (NAS)
Dandle•LION products provide supportive care for infants with NAS Caring for the Infant with Neonatal Abstinence Syndrome (NAS) According to the American Academy of Pediatrics (2012), nonpharmacologic care strategies should comprise the initial approach to therapy in treating Neonatal Abstinence Syndrome. NAS is a self-limiting condition where the primary goal of the care team is to decrease symptoms without extraneous pharmacological and medical intervention. Successful management of neonatal withdrawal symptoms rests on a foundation of supportive care for mother and infant, with active participation from a multi-disciplinary care team. Evidence- based strategies include providing a calm environment with decreased visual and auditory stimuli, promoting sleep for parents and infant, providing positive proprioceptive and tactile sensory input, and maximizing nutrition to promote weight gain. Ideally, infant and family remain together for the duration of the hospital stay in a quiet, protected environment with Therapeutic Positioning Skin Protection Therapeutic Touch Protective Environment medical and psychosocial support that continues beyond hospitalization. The DandleWRAP Stretch is Preventing diaper dermatitis is Infant massage provides babies Swaddled, immersion bathing designed to support irritable, hard- essential to promoting comfort in with a positive tactile experience promotes temperature stability to-console babies. The lightweight, babies with NAS. Frequent stooling that promotes proprioception and creates a relaxing and calm American Academy of Pediatrics (2017). Alternative treatment approach for neonatal Holmes, A., Atwood, E. Whalen, B. Beliveau, J., Jarvis, J., Matulis, J. & Ralston, S. (2016). abstinence syndrome may shorten hospital stay. AAP News. Accessed online September Rooming-in to treat neonatal abstinence syndrome: Improved family-centered care at lower moisture-wicking fabric reduces can change the pH of the baby’s and encourages development experience for irritable babies. -
Neonatal Abstinence Syndrome Guideline
Neonatal Abstinence Syndrome MENU Introduction Incidence and risk factors 1. Risk factors for illicit drug use 2. Risk factors for adverse pregnancy outcomes 3. Risk factors for neonatal abstinence syndrome Consequences 1. Tobacco 2. Alcohol 3. Amphetamines 4. Cocaine and derivatives 5. Marijuana 6. Opiates 7. Polydrug use Diagnosis 1. Drug use in pregnancy 2. Testing of newborns 3. Diagnosis of withdrawal Interventions 1. Antenatal care a. Treatment of pregnant users of illicit drugs b. Smoking in pregnancy c. Support from caregivers for pregnant women abusing drugs 2. Postnatal care 3. Pharmacological treatment a. Opioid withdrawal: MORPHINE REGIMEN b. Non-opioid CNS depressants: PHENOBARBITONE REGIMEN c. Management of the vomiting baby Discharge The Drug use in pregnancy team Infant protection issues Follow-Up Keypoints References Introduction: Pregnant women using drugs have the same anxieties and expectations as other pregnant women. All women using drugs are entitled to accurate information, and to be treated sensitively in a non-judgmental manner. Maternal illicit drug use is a risk factor for adverse pregnancy and neonatal outcomes including preterm birth. Infants born to mothers using illicit drugs (and alcohol and tobacco) are at risk of the toxic effects of the drugs both in-utero and ex-utero; adverse pregnancy and neonatal outcomes related to the poor socioeconomic situations and lifestyle factors associated with illicit drug use; neonatal drug withdrawal; and the subsequent poor outcomes of infants reared in a socioeconomically disadvantaged environment. The Report of the US Preventative Services Task Force 1996 1 and the monograph review by Bell and Lau 2 1995 are used as background for the content of this guideline. -
Neonatal Drug Withdrawal Abstract
Guidance for the Clinician in Rendering Pediatric Care CLINICAL REPORT Neonatal Drug Withdrawal Mark L. Hudak, MD, Rosemarie C. Tan, MD,, PhD, THE abstract COMMITTEE ON DRUGS, and THE COMMITTEE ON FETUS AND Maternal use of certain drugs during pregnancy can result in transient NEWBORN neonatal signs consistent with withdrawal or acute toxicity or cause KEY WORDS opioid, methadone, heroin, fentanyl, benzodiazepine, cocaine, sustained signs consistent with a lasting drug effect. In addition, hos- methamphetamine, SSRI, drug withdrawal, neonate, abstinence pitalized infants who are treated with opioids or benzodiazepines to syndrome provide analgesia or sedation may be at risk for manifesting signs ABBREVIATIONS of withdrawal. This statement updates information about the clinical CNS—central nervous system — presentation of infants exposed to intrauterine drugs and the thera- DTO diluted tincture of opium ECMO—extracorporeal membrane oxygenation peutic options for treatment of withdrawal and is expanded to include FDA—Food and Drug Administration evidence-based approaches to the management of the hospitalized in- 5-HIAA—5-hydroxyindoleacetic acid fant who requires weaning from analgesics or sedatives. Pediatrics ICD-9—International Classification of Diseases, Ninth Revision — – NAS neonatal abstinence syndrome 2012;129:e540 e560 SSRI—selective serotonin reuptake inhibitor INTRODUCTION This document is copyrighted and is property of the American fi Academy of Pediatrics and its Board of Directors. All authors Use and abuse of drugs, alcohol, and tobacco contribute signi cantly have filed conflict of interest statements with the American to the health burden of society. The 2009 National Survey on Drug Use Academy of Pediatrics. Any conflicts have been resolved through and Health reported that recent (within the past month) use of illicit a process approved by the Board of Directors. -
Finnegan Neonatal Abstinence Scoring System: Normal Values for First 3 Days and Weeks 5–6 in Non-Addicted Infantsadd 2802 524
RESEARCH REPORT doi:10.1111/j.1360-0443.2009.02802.x Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5–6 in non-addicted infantsadd_2802 524..528 Urs Zimmermann-Baer1,2, Ursula Nötzli1, Katharina Rentsch3 & Hans Ulrich Bucher1 Division of Neonatology, Department of Obstetrics and Gynecology, University Hospital Zurich, Switzerland,1 Division of Neonatology, Department of Pediatrics, Children’s Hospital, Kantonsspital Winterthur, Switzerland2 and Institute for Clinical Chemistry, University Hospital Zurich, Switzerland3 ABSTRACT Objective The neonatal abstinence scoring system proposed by Finnegan is used widely in neonatal units to initiate and to guide therapy in babies of opiate-dependent mothers. The purpose of this study was to assess the variability of the scores in newborns and infants not exposed to opiates during the first 3 days of life and during 3 consecutive days in weeks 5 or 6. Patients and methods Healthy neonates born after 34 completed weeks of gestation, whose parents denied opiate consumption and gave informed consent, were included in this observational study.Infants with signs or symptoms of disease or with feeding problems were excluded. A modified scoring system was used every 8 hours during 72 hours by trained nurses; 102 neonates were observed for the first 3 days of life and 26 neonates in weeks 5–6. A meconium sample and a urine sample at weeks 5–6 were stored from all infants to be analysed for drugs when the baby scored high. Given a non-Gaussian distribution the scores were represented as percentiles. Results During the first 3 days of life median scores remained stable at 2 but the variability increased, with the 95th percentile rising from 5.5 on day 1 to 7 on day 2. -
Newborn Care 2 Table of Contents
Newborn Care 2 Table of Contents Your Newborn ............................................ 4 Baby Basics ............................................... 16 Preparing for Your Baby ................................. 4 Stools ................................................................. 16 What to Expect in the Hospital ....................... 4 Wet Diapers ..................................................... 16 Your Newborn ................................................... 5 Diapering .......................................................... 16 Bathing .............................................................. 17 Comfort and Bonding ............................ 7 Skin Care .......................................................... 17 Handling Your Baby ......................................... 7 Fingernail Care ................................................ 17 Interacting with Your Baby ............................. 7 Umbilical Cord Care ....................................... 17 Crying and Comfort ......................................... 7 Circumcision Care .......................................... 17 Bonding with Baby ............................................ 9 Infant Development ........................................ 10 Health and Safety ................................. 18 Baby Wearing .................................................. 11 Sleep Safety ....................................................... 18 SUID and SIDS ................................................ 18 Sleep.............................................................. -
Simplification of the Finnegan Neonatal Abstinence Scoring System: Retrospective Study of Two Institutions in the USA
Open Access Research BMJ Open: first published as 10.1136/bmjopen-2017-016176 on 27 September 2017. Downloaded from Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA Enrique Gomez Pomar,1 Loretta P Finnegan,2 Lori Devlin,3 Henrietta Bada,1 Vanessa A Concina,1 Katrina T Ibonia,1 Philip M Westgate4 To cite: Gomez Pomar E, ABSTRACT Strengths and limitations of this study Finnegan LP, Devlin L, et al. Objective To develop a simplified Finnegan Neonatal Simplification of the Finnegan Abstinence Scoring System (sFNAS) that will highly ► A simplified scoring system (simplified Finnegan Neonatal Abstinence Scoring correlate with scores ≥8 and ≥12 in infants being System: retrospective Neonatal Abstinence Scoring System (sFNAS)) is assessed with the FNAS. study of two institutions proposed developed from a large data set and cross- Design, setting and participants This is a in the USA. BMJ Open validated using a database from another institution. retrospective analysis involving 367 patients admitted to 2017;7:e016176. doi:10.1136/ ► Cutoff values are provided for the sFNAS which two level IV neonatal intensive care units with a total of bmjopen-2017-016176 predict the cutoff value. 40 294 observations. Inclusion criteria included neonates ► The retrospective nature of our study requires ► Prepublication history for with gestational age ≥37 0/7 weeks, who are being this paper is available online. prospective validation of the inter-rater reliability of assessed for neonatal abstinence syndrome (NAS) using To view these files, please visit the sFNAS and also the clinical validity of this tool. -
Breastfeeding Matters
Breastfeeding Matters An important guide for breastfeeding families ACKNOWLEDGEMENTS Best Start by Health Nexus would like to thank the Public Health Units of Ontario who supported the creation and development of this provincial resource and generously shared their resources and expertise. We would also like to thank the parents and the experts who provided input for this booklet. Final review was done by Marg La Salle, RN, BScN, IBCLC, and BFI Lead Assessor. The information in this booklet is current at the time of production but information can change over time. Every effort will be made to ensure the information remains current. Throughout this resource, gender-specific language such as “woman”, “women” and “mother” is used in order to accurately cite the research referred to. We intend these terms to refer to all childbearing individuals, regardless of their gender identity or sexual orientation. Funded by the Government of Ontario. Table of Contents SECTION 1 .......................... 3 SECTION 4 ........................ 27 The Importance of Breastfeeding Important Things to Know • Risks of Not Breastfeeding • Waking a Sleepy Baby • Your Breastfeeding Rights • Calming a Fussy Baby • The Baby-Friendly Initiative • Burping Your Baby • Making an Informed Decision • Growth Spurts • Family Support • Sore Nipples • Peer Support • Using a Pacifier (Soother) • Engorgement SECTION 2 ........................ 11 • Storing Your Breast Milk Helping Your Baby Get a Good Start • Skin-to-Skin SECTION 5 ........................ 33 • Safe Positioning -
Practice Resource: CARE of the NEWBORN EXPOSED to SUBSTANCES DURING PREGNANCY
Care of the Newborn Exposed to Substances During Pregnancy Practice Resource for Health Care Providers November 2020 Practice Resource: CARE OF THE NEWBORN EXPOSED TO SUBSTANCES DURING PREGNANCY © 2020 Perinatal Services BC Suggested Citation: Perinatal Services BC. (November 2020). Care of the Newborn Exposed to Substances During Pregnancy: Instructional Manual. Vancouver, BC. All rights reserved. No part of this publication may be reproduced for commercial purposes without prior written permission from Perinatal Services BC. Requests for permission should be directed to: Perinatal Services BC Suite 260 1770 West 7th Avenue Vancouver, BC V6J 4Y6 T: 604-877-2121 F: 604-872-1987 [email protected] www.perinatalservicesbc.ca This manual was designed in partnership by UBC Faculty of Medicine’s Division of Continuing Professional Development (UBC CPD), Perinatal Services BC (PSBC), BC Women’s Hospital & Health Centre (BCW) and Fraser Health. Content in this manual was derived from module 3: Care of the newborn exposed to substances during pregnancy in the online module series, Perinatal Substance Use, available from https://ubccpd.ca/course/perinatal-substance-use Perinatal Services BC Care of the Newborn Exposed to Substances During Pregnancy ii Limitations of Scope Iatrogenic opioid withdrawal: Infants recovering from serious illness who received opioids and sedatives in the hospital may experience symptoms of withdrawal once the drug is discontinued or tapered too quickly. While these infants may benefit from the management strategies discussed in this module, the ESC Care Tool is intended for newborns with prenatal substance exposure. Language A note about gender and sexual orientation terminology: In this module, the terms pregnant women and pregnant individual are used. -
Opioid-Exposed Mother/Baby Dyads & Breastfeeding
BREASTFEEDING MEDICINE Volume 13, Number 4, 2018 Clinical Research ª Mary Ann Liebert, Inc. DOI: 10.1089/bfm.2017.0172 Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads Davida M. Schiff,1,2 Elisha M. Wachman,1 Barbara Philipp,1 Kathleen Joseph,3 Hira Shrestha,1 Elsie M. Taveras,2 and Margaret G.K. Parker1 Abstract Objectives: Among opioid-exposed newborns, breastfeeding is associated with less severe withdrawal signs, yet breastfeeding rates remain low. We determined the extent to which hospital, maternal, and infant characteristics are associated with breastfeeding initiation and continuation among opioid-exposed dyads. Materials and Methods: We examined breastfeeding initiation and continuation until infants’ discharge among opioid-exposed dyads from 2006 to 2016. Among dyads meeting hospital breastfeeding guidelines, we assessed hospital (changes in breastfeeding guidelines and improvement initiatives [using delivery year as a proxy]), maternal (demographics, comorbid conditions, methadone versus buprenorphine treatment, and delivery mode), and infant (gestational age and birth weight) characteristics. We used multivariable logistic regression to examine independent associations of characteristics with breastfeeding initiation and continuation. Results: Among 924 opioid-exposed dyads, 61% (564) met breastfeeding criteria. Overall, 50% (283/564) of dyads initiated and 33% (187/564) continued breastfeeding until discharge. Breastfeeding initiation and con- tinuation rates increased from 38% and 8% in 2006, to 56% and 34% in 2016, respectively. In adjusted models, infants born after reducing restrictions in hospital breastfeeding guidelines and prenatal breastfeeding education (adjusted odds ratio, aOR 2.6 [95% confidence interval, CI 1.5–4.5]) had increased odds of receiving any maternal breast milk versus infants born with earlier hospital policies. -
USIT Exam Answer
American Board of Family Medicine 2018 IN-TRAINING EXAMINATION CRITIQUE BOOK This book contains the answers to each question in the In-Training Examination, as well as a critique that provides a rationale for the correct answer. Bibliographic references are included at the end of each critique to facilitate any further study you may wish to do in a particular area. Copyright© 2018 The American Board of Family Medicine, Inc. All rights reserved. Item 1 ANSWER: E A urine test for Legionella pneumophila antigen is the preferred method to confirm Legionnaires’ disease. This test is rapid and will only detect Legionella pneumophila antigen. A sputum culture is the gold standard for the diagnosis of Legionnaires’ disease but it requires 48–72 hours. A chest radiograph does not confirm the diagnosis but may show the extent of disease. Responding to antibiotic treatment does not confirm a specific diagnosis. Ref: Mercante JW, Winchell JM: Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev 2015;28(1):95-133. 2) National Center for Immunization and Respiratory Diseases: Legionella (Legionnaires’ disease and Pontiac fever): Diagnosis, treatment, and prevention. Centers for Disease Control and Prevention, 2017. Item 2 ANSWER: C Risk factors for developmental dysplasia of the hip in infants include a breech presentation in the third trimester, regardless of whether the delivery was cesarean or vaginal. Other indications to evaluate an infant for this condition include a positive family history, a history of previous clinical instability, parental concern, a history of improper swaddling, and a suspicious or inconclusive physical examination. -
Safer Swaddling
Safer Swaddling Although swaddling has been practiced for years, recent studies show that swaddling for sleep can put your baby at risk of suffocation. If you have tried calming your baby and nothing has worked, you can try swaddling to settle your crying baby. What are the risks of swaddling? Swaddling can get in the way of Swaddling for sleep may result in mother- baby bonding and newborn sudden infant death feeding g Loose fabric can cover baby’s face and Skin-to-skin contact between mother and baby cause suffocation. has many benefits. It helps you develop your g If the baby becomes unwrapped, the fabric relationship with your baby, helps reduce your can become wrapped around baby’s neck and baby’s stress, promotes more restful sleep and cause strangulation. helps with breastfeeding. g The baby may roll onto his or her stomach and be unable to roll back . Tight swaddling can be risky g Babies wrapped in blankets or heavy fabrics g Tight swaddling can interfere with breathing can get too hot, which increases the risk of and can even lead to pneumonia. Your baby Sudden Infant Death Syndrome (SIDS). must have enough room for his or her chest g Sleeping with a baby on a bed or couch greatly to move. increases the risk of sudden infant death and g It can cause long-term hip problems. Your suffocation. This risk is even higher when a baby must have enough room to freely move baby is swaddled. the hips and legs. January 2016 When to stop swaddling baby When baby can roll or is able to unravel the wrap, it is time to stop swaddling because the loose fabric creates a suffocation or strangulation risk. -
STRONG UNION Actor Gabrielle Union Urges Women Not to Put Off Breast-Cancer Screenings PG
DOWNLOAD THIS ISSUE ON YOUR TABLET FOR FREE FROM THE APP STORE OR GOOGLE PLAY! October 2016 $4.95 CANCER RESEARCH CANINE MEN’S THERAPIES HEALTH OFFER 5 Key HOPE FOR HEALTHY Cancer Signs HUMANS BEAUTY pg. 13 PG. 34 The Deal With FOOD Chemical Peels FAMILY & pg. 16 PARENTING Tasty Apple Making Shots Dishes for Fall pg. 40 CHECKUP Less Scary pg. 23 Advances in Breast Cancer pg. 44 LIVING HEALTHY Workout Recovery Tips pg. 12 STRONG UNION Actor Gabrielle Union urges women not to put off breast-cancer screenings PG. 28 OCTOBER 2016 Contents FEATURES Pg. 28 Download WebMD Magazine You’ve Got for FREE on the App Store and a Friend Google Play. Gabrielle Union knows all too well the pain of breast cancer. She lost one of her closest friends to the disease in 2010. Today she’s dedicated to spreading the I HAVE TO word about the importance MAKE SURE of breast cancer screening. MY HEALTH“ “ IS GREAT—SO I’M AROUND TO HELP MY The Canine FAMILY. Connection Promising new research looks at how treatments used to help dogs with cancer could one day help humans with the disease. IN EVERY ISSUE Pg. 4 EDITOR’S NOTE TAKE 10 Sonequa Martin- Green of The Walking Dead shares how a family history of cancer spurred her to become a health activist. Plus, she reveals her favorite Pg. health advice and her 34 ultimate “cheat food.” Pg. Cover Photograph by Alexei Hay/Trunk Archive 49 W ebMD.COM 2 OCTOBER 2016 Contents OCTOBER 2016 HEALTHY START Pg.